Advertisement
AZTA vs ICLR
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTA is a Hold and ICLR is a Hold.
Aroon Indicator for AZTA shows an upward move is likely
AZTA's Aroon Indicator triggered a bullish signal on October 14, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 177 similar instances where the Aroon Indicator showed a similar pattern. In 144 of the 177 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 81%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Momentum Indicator moved above the 0 level on September 15, 2026. You may want to consider a long position or call options on AZTA as a result. In 64 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.
The Moving Average Convergence Divergence (MACD) for AZTA just turned positive on September 17, 2026. Looking at past instances where AZTA's MACD turned positive, the stock continued to rise in 38 of 49 cases over the following month. The odds of a continued upward trend are 78%.
Following a +0.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where AZTA advanced for three days, in 217 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
Bearish Trend Analysis
The 10-day RSI Indicator for AZTA moved out of overbought territory on October 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 23 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 74%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AZTA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
AZTA broke above its upper Bollinger Band on October 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. AZTA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.994) is normal, around the industry mean (5.011). P/E Ratio (42.431) is within average values for comparable stocks, (163.451). Projected Growth (PEG Ratio) (0.310) is also within normal values, averaging (4.456). Dividend Yield (0.002) settles around the average of (0.005) among similar stocks. P/S Ratio (2.485) is also within normal values, averaging (56.074).
The Tickeron PE Growth Rating for this company is 84 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AZTA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.
ICLR sees MACD Histogram crosses below signal line
ICLR saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 01, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 43 instances where the indicator turned negative. In 34 of the 43 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 79%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ICLR as a result. In 65 of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 67%.
The 10-day moving average for ICLR crossed bearishly below the 50-day moving average on October 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 56%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICLR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 38 of 55 cases where ICLR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 69%.
ICLR moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +1.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where ICLR advanced for three days, in 203 of 309 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The Aroon Indicator entered an Uptrend today. In 156 of 220 cases where ICLR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating fairly steady price growth. ICLR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 83 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.444) is normal, around the industry mean (72.578). P/E Ratio (270.092) is within average values for comparable stocks, (146.993). Projected Growth (PEG Ratio) (0.533) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.001) among similar stocks. P/S Ratio (1.626) is also within normal values, averaging (9.775).
The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICLR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.
AZTA | ICLR | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 39 | 88 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 48 Fair valued | 83 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 93 | 90 | |
PRICE GROWTH RATING 1..100 | 36 | 47 | |
P/E GROWTH RATING 1..100 | 84 | 2 | |
SEASONALITY SCORE 1..100 | 4 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AZTA's Valuation (48) in the Electronic Production Equipment industry is somewhat better than the same rating for ICLR (83) in the Pharmaceuticals Other industry. This means that AZTA’s stock grew somewhat faster than ICLR’s over the last 12 months.
AZTA's Profit vs Risk Rating (100) in the Electronic Production Equipment industry is in the same range as ICLR (100) in the Pharmaceuticals Other industry. This means that AZTA’s stock grew similarly to ICLR’s over the last 12 months.
ICLR's SMR Rating (90) in the Pharmaceuticals Other industry is in the same range as AZTA (93) in the Electronic Production Equipment industry. This means that ICLR’s stock grew similarly to AZTA’s over the last 12 months.
AZTA's Price Growth Rating (36) in the Electronic Production Equipment industry is in the same range as ICLR (47) in the Pharmaceuticals Other industry. This means that AZTA’s stock grew similarly to ICLR’s over the last 12 months.
ICLR's P/E Growth Rating (2) in the Pharmaceuticals Other industry is significantly better than the same rating for AZTA (84) in the Electronic Production Equipment industry. This means that ICLR’s stock grew significantly faster than AZTA’s over the last 12 months.
| AZTA | ICLR | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 74% | N/A |
| Stochastic ODDS (%) | 1 day ago 69% | 1 day ago 69% |
| Momentum ODDS (%) | 1 day ago 76% | 1 day ago 67% |
| MACD ODDS (%) | 1 day ago 78% | 1 day ago 79% |
| TrendWeek ODDS (%) | 1 day ago 72% | 1 day ago 68% |
| TrendMonth ODDS (%) | 1 day ago 75% | 1 day ago 68% |
| Advances ODDS (%) | 2 days ago 72% | 7 days ago 66% |
| Declines ODDS (%) | 8 days ago 81% | 14 days ago 70% |
| BollingerBands ODDS (%) | 1 day ago 78% | N/A |
| Aroon ODDS (%) | 1 day ago 81% | 1 day ago 71% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AZTA’s FA Score shows that 0 FA rating(s) are green while ICLR’s FA Score has 1 green FA rating(s).
- AZTA’s FA Score: 0 green, 5 red.
- ICLR’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AZTA’s TA Score shows that 5 TA indicator(s) are bullish while ICLR’s TA Score has 4 bullish TA indicator(s).
- AZTA’s TA Score: 5 bullish, 3 bearish.
- ICLR’s TA Score: 4 bullish, 4 bearish.
Price Growth
AZTA (@Pharmaceuticals: Other) experienced а +3.59% price change this week, while ICLR (@Medical Specialties) price change was +2.98% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.96%. For the same industry, the average monthly price growth was -4.87%, and the average quarterly price growth was +3.79%.
The average weekly price growth across all stocks in the @Medical Specialties industry was -3.43%. For the same industry, the average monthly price growth was -0.17%, and the average quarterly price growth was +34.76%.
Reported Earning Dates
AZTA is expected to report earnings on Nov 17, 2026.
ICLR is expected to report earnings on Oct 27, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (-0.96% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical Specialties (-3.43% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
Advertisement
AZTA and
Correlation & Price change
A.I.dvisor indicates that over the last year, AZTA has been loosely correlated with IQV. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if AZTA jumps, then IQV could also see price increases.
| Ticker / NAME | Correlation To AZTA | 1D Price Change % | ||
|---|---|---|---|---|
| AZTA | 100% | -1.82% | ||
| IQV - AZTA | 60% Loosely correlated | +0.51% | ||
| RVTY - AZTA | 59% Loosely correlated | -1.91% | ||
| A - AZTA | 59% Loosely correlated | +1.40% | ||
| MTD - AZTA | 59% Loosely correlated | +0.70% | ||
| BRKR - AZTA | 58% Loosely correlated | -1.05% | ||
More | ||||